Safwan Elkhatib, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nasal Lavage Fluid | 1 | 2021 | 17 | 0.770 |
Why?
|
| Neuroimmunomodulation | 2 | 2021 | 186 | 0.750 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2022 | 365 | 0.720 |
Why?
|
| Influenza A virus | 1 | 2021 | 453 | 0.580 |
Why?
|
| Interleukin-17 | 2 | 2024 | 921 | 0.550 |
Why?
|
| Oncogene Proteins | 1 | 2019 | 710 | 0.470 |
Why?
|
| Autonomic Nervous System | 1 | 2019 | 706 | 0.450 |
Why?
|
| Leukocytes | 1 | 2021 | 2027 | 0.430 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2019 | 1608 | 0.360 |
Why?
|
| Neutrophils | 1 | 2021 | 3776 | 0.310 |
Why?
|
| Carcinoma | 1 | 2019 | 2312 | 0.280 |
Why?
|
| Th17 Cells | 2 | 2024 | 786 | 0.270 |
Why?
|
| Stress, Psychological | 2 | 2024 | 4533 | 0.260 |
Why?
|
| Exercise | 1 | 2021 | 5937 | 0.230 |
Why?
|
| Head and Neck Neoplasms | 1 | 2019 | 2921 | 0.230 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 5783 | 0.230 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2024 | 216 | 0.220 |
Why?
|
| Lung | 1 | 2021 | 10033 | 0.210 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 4628 | 0.200 |
Why?
|
| Nasal Lavage | 1 | 2021 | 17 | 0.190 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 10261 | 0.190 |
Why?
|
| Catecholamines | 1 | 2022 | 383 | 0.180 |
Why?
|
| Superoxides | 1 | 2022 | 383 | 0.180 |
Why?
|
| Cyclic AMP | 1 | 2024 | 1467 | 0.170 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 755 | 0.160 |
Why?
|
| Nasal Mucosa | 1 | 2021 | 416 | 0.150 |
Why?
|
| Neurotransmitter Agents | 1 | 2019 | 663 | 0.120 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1831 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 22332 | 0.110 |
Why?
|
| Social Behavior | 1 | 2020 | 1146 | 0.110 |
Why?
|
| Memory Disorders | 1 | 2021 | 1194 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 15652 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 6220 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2020 | 1865 | 0.100 |
Why?
|
| Mice | 4 | 2024 | 81819 | 0.090 |
Why?
|
| Inflammation | 2 | 2022 | 10850 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2024 | 3111 | 0.090 |
Why?
|
| Animals | 5 | 2024 | 168764 | 0.080 |
Why?
|
| Sinusitis | 1 | 2019 | 995 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2024 | 23601 | 0.080 |
Why?
|
| Gene Expression | 1 | 2021 | 7584 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 3596 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 18293 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2024 | 52 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2024 | 242 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12976 | 0.050 |
Why?
|
| Time Factors | 1 | 2021 | 40065 | 0.040 |
Why?
|
| Humans | 5 | 2022 | 765968 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2024 | 1237 | 0.040 |
Why?
|
| Young Adult | 1 | 2021 | 59889 | 0.030 |
Why?
|
| Mutation | 1 | 2019 | 30198 | 0.030 |
Why?
|
| Female | 3 | 2024 | 396112 | 0.030 |
Why?
|
| Adolescent | 1 | 2021 | 88835 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2024 | 14448 | 0.020 |
Why?
|
| Male | 2 | 2024 | 363698 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2024 | 11641 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 223044 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 223009 | 0.010 |
Why?
|